dosing for glp-1 Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses. http://ms.spr.ly/6188SW4Iw The AFFORDABLE Flex-Dosing GLP-1/GIP Injection

Investigated various glutathione derivatives in vitro and found that certain forms (e.g., GSHMEE) effectively reduce melanin and tyrosinase activity, increasing the pheomelanin/eumelanin ratio

Comparison of qSOFA score, SOFA score, and SIRS criteria for the prediction of infection and mortality among surgical intermediate and intensive care patients

Beuming T et al (2008): The binding sites for cocaine and dopamine in the dopamine transporter overlap

The math isn't taught in the product insert, and most peptide suppliers don't provide protocol-aligned vial size recommendations

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer